|
|||||
|
|
The efficacy and safety of apremilast,etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb,randomized, placebo‐controlled trial (LIBERATE) |
|
| Authors: | K. Reich M. Gooderham L. Green A. Bewley Z. Zhang I. Khanskaya R.M. Day J. Goncalves K. Shah V. Piguet J. Soung |
| Affiliation: | 1. SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany;2. SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada;3. George Washington University School of Medicine, Washington, DC, USA;4. Whipps Cross University Hospital & the Royal London Hospital, London, UK;5. Celgene Corporation, Summit, NJ, USA;6. Cardiff University and University Hospital of Wales, Wales, UK;7. Southern California Dermatology, Santa Ana, CA, USA |
| Abstract: | |
| Keywords: | |